ChainPeptides has developed a peptide-based antimicrobial technology that is effective against a wide spectrum of microorganisms. It can be used in medical devices to minimize the incidence and severity of HAIs. By using our chain peptide-based technology into their medical devices, manufacturers will be able to offer products with cutting-edge qualities to address microbial infections, particularly those triggered by antibiotic-resistant strains. In-vitro tests on our main product have produced exciting and encouraging results.
Our products offer a potent solution to the rising problem of HAIs, lowering morbidity and mortality while also lessening the economic burden on healthcare resources.
Reduced use of antibiotic drugs
Decrease in morbidity and mortality
Decreased number of days of hospital stay
Lower financial burden on healthcare resources
Improved quality of life of the patients
Escherichiacoli ATCC 25922
Klebsiellapneumoniae ATCC 10031
Pseudomonasaeruginosa ATCC 27853
Staphylococcusaureus ATCC 25923
Contact us to know more about our productand about available licenses